AKO Capital: 9 Edwards Lifesciences transactions (AKO Capital LLP /

9 AKO Capital Edwards Lifesciences Trades

The first Edwards Lifesciences trade was made in Q2 2018. Since then AKO Capital bought shares five more times and sold shares on three occasions. The investor completely sold their stake between Q1 2020 and Q2 2020.

Avg closing price

Price range

Sold -2.26M shares Q2 2020

Avg closing price $71.07

Price range $57.54 - $76.95

Sold 9.0% shares (-225k shares) Q1 2020

Avg closing price $72.12

Price range $52.41 - $81.00

Increased shares by 28.7% (+555k shares) Q4 2019

Avg closing price $78.09

Price range $71.70 - $82.09

Increased shares by 12.8% (+220k shares) Q3 2019

Avg closing price $70.25

Price range $61.55 - $75.43

Increased shares by 24.4% (+336k shares) Q2 2019

Avg closing price $60.47

Price range $55.74 - $64.41

Increased shares by 64.8% (+541k shares) Q1 2019

Avg closing price $57.07

Price range $47.89 - $64.05

Increased shares by 27.7% (+181k shares) Q4 2018

Avg closing price $50.60

Price range $46.41 - $56.94

Sold 10.5% shares (-76.6k shares) Q3 2018

Avg closing price $48.91

Price range $45.70 - $58.03

New holding (+730k shares) Q2 2018

Avg closing price $46.67

Price range $42.45 - $51.30

News about Edwards Lifesciences Corp and AKO Capital

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman

EW Investors with Losses Encouraged to Contact the Firm Before Dec. 13, 2024 Deadline SAN FRANCISCO, CA / ACCESSWIRE / December 3, 2024 / Hagens Berman urges...

accesswire.com, 9 months ago

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman

SAN FRANCISCO, Dec. 01, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to...

globenewswire.com, 9 months ago

Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman

SAN FRANCISCO, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to...

globenewswire.com, 9 months ago

Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman

SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to...

globenewswire.com, 9 months ago

Never miss a trade

早乙女迅雷

AKO Capital Edwards Lifesciences Corp

Current Value of Holding

Shares

% of Portfolio

Average Buy Price

9 AKO Capital Edwards Lifesciences Trades

News about Edwards Lifesciences Corp and AKO Capital

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman

Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman

Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman

早乙女迅雷

AKO Capital Edwards Lifesciences Corp

9 AKO Capital Edwards Lifesciences Trades

News about Edwards Lifesciences Corp and AKO Capital

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action - Hagens Berman

After Losing Over $16 Billion Of Market Capitalization Edwards Lifesciences (EW) Faces Investor Class Action – Hagens Berman

Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman

Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization – Hagens Berman

Embed chart